Yesterday, March 30, 2016, 46 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $34.31 to $30,062,500.00.

Highlighted Stocks Traded by Insiders:

Southern National Bancorp of Virginia (SONA) - FREE Research Report

Call Neil J, who is Director at Southern National Bancorp of Virginia, bought 224 shares at $12.24 on March 30, 2016. Following this transaction, the Director owned 99,568 shares meaning that the stake was boosted by 0.23% with the 224-share transaction.

The shares most recently traded at $12.22, down $0.02, or 0.17% since the insider transaction. Historical insider transactions for Southern National Bancorp of Virginia go as follows:

  • 4-Week # shares bought: 2,000
  • 12-Week # shares bought: 13,834
  • 24-Week # shares bought: 47,107

The average volume for Southern National Bancorp of Virginia has been 12,700 shares per day over the past 30 days. Southern National Bancorp of Virginia has a market cap of $149.1 million and is part of the financial sector and banking industry. Shares are down 6.74% year-to-date as of the close of trading on Wednesday.

Southern National Bancorp of Virginia, Inc. operates as the bank holding company for Sonabank that provides commercial banking services to middle market corporate clients and retail clients in the United States. The stock currently has a dividend yield of 2.63%. The company has a P/E ratio of 16.2. Currently, there is 1 analyst who rates Southern National Bancorp of Virginia a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SONA - FREE

TheStreet Quant Ratings

rates Southern National Bancorp of Virginia as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, expanding profit margins, impressive record of earnings per share growth and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

Southern National Bancorp of Virginia Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Ellie Mae (ELLI) - FREE Research Report

Hu Limin, who is Evp, Cto at Ellie Mae, sold 2,488 shares at $85.42 on March 30, 2016. Following this transaction, the Evp, Cto owned 207,999 shares meaning that the stake was reduced by 1.18% with the 2,488-share transaction.

Luce Edgar, who is Chief Financial Officer at Ellie Mae, sold 2,926 shares at $84.12 on March 30, 2016. Following this transaction, the Chief Financial Officer owned 66,596 shares meaning that the stake was reduced by 4.21% with the 2,926-share transaction.

Tyrrell Joseph P., who is EVP, Corporate Strategy at Ellie Mae, sold 2,580 shares at $85.41 on March 30, 2016. Following this transaction, the EVP, Corporate Strategy owned 35,197 shares meaning that the stake was reduced by 6.83% with the 2,580-share transaction.

Schreiner Gates Cathleen, who is EVP, Sales & Marketing at Ellie Mae, sold 978 shares at $83.99 on March 30, 2016. Following this transaction, the EVP, Sales & Marketing owned 29,991 shares meaning that the stake was reduced by 3.16% with the 978-share transaction.

The shares most recently traded at $89.65, up $5.66, or 6.31% since the insider transaction. Historical insider transactions for Ellie Mae go as follows:

  • 4-Week # shares bought: 1,005
  • 4-Week # shares sold: 65,713
  • 12-Week # shares bought: 1,005
  • 12-Week # shares sold: 130,409
  • 24-Week # shares bought: 1,005
  • 24-Week # shares sold: 143,134

The average volume for Ellie Mae has been 847,300 shares per day over the past 30 days. Ellie Mae has a market cap of $2.6 billion and is part of the technology sector and computer software & services industry. Shares are up 45.91% year-to-date as of the close of trading on Wednesday.

Ellie Mae, Inc. The company has a P/E ratio of 120.8. Currently, there are 5 analysts who rate Ellie Mae a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ELLI - FREE

TheStreet Quant Ratings

rates Ellie Mae as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and good cash flow from operations. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Ellie Mae Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hydrogenics (HYGS) - FREE Research Report

CommScope, Inc. of North Carolina, who is 10% Owner at Hydrogenics, sold 18,133 shares at $8.21 on March 30, 2016. Following this transaction, the 10% Owner owned 1.3 million shares meaning that the stake was reduced by 1.39% with the 18,133-share transaction.

The shares most recently traded at $8.39, up $0.18, or 2.11% since the insider transaction. Historical insider transactions for Hydrogenics go as follows:

  • 4-Week # shares sold: 26,403
  • 12-Week # shares sold: 26,403
  • 24-Week # shares sold: 26,403

The average volume for Hydrogenics has been 58,700 shares per day over the past 30 days. Hydrogenics has a market cap of $105.2 million and is part of the industrial goods sector and industrial industry. Shares are down 5.36% year-to-date as of the close of trading on Wednesday.

Hydrogenics Corporation, together with its subsidiaries, designs, develops, and manufactures hydrogen generation products based on water electrolysis technology; and fuel cell products based on proton exchange membrane technology. Currently, there are 3 analysts who rate Hydrogenics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HYGS - FREE

TheStreet Quant Ratings

rates Hydrogenics as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk, disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full

Hydrogenics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.